Crispr Therapeutics shares owned by Chesapeake Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Chesapeake Asset Management
from 13F filings
Historical chart of Chesapeake Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Chesapeake Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Crispr Therapeutics by Chesapeake Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $11k | 200 | 52.44 |
More positions owned by Chesapeake Asset Management
View all positions for Chesapeake Asset Management